183 related articles for article (PubMed ID: 22492598)
1. Design and evaluation of patches for transdermal delivery of losartan potassium.
Baviskar DT; Parik VB; Gupta HN; Maniyar AH; Jain DK
PDA J Pharm Sci Technol; 2012; 66(2):126-35. PubMed ID: 22492598
[TBL] [Abstract][Full Text] [Related]
2. Development of matrix-type transdermal delivery of lornoxicam: in vitro evaluation and pharmacodynamic and pharmacokinetic studies in albino rats.
Baviskar DT; Parik VB; Jain DJ
PDA J Pharm Sci Technol; 2013; 67(1):9-22. PubMed ID: 23385560
[TBL] [Abstract][Full Text] [Related]
3. Formulation of Polymers-Based Methotrexate Patches and Investigation of the Effect of Various Penetration Enhancers: In Vitro, Ex Vivo and In Vivo Characterization.
Latif MS; Nawaz A; Rashid SA; Akhlaq M; Iqbal A; Khan MJ; Khan MS; Lim V; Alfatama M
Polymers (Basel); 2022 May; 14(11):. PubMed ID: 35683883
[TBL] [Abstract][Full Text] [Related]
4. Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation.
Saoji SD; Atram SC; Dhore PW; Deole PS; Raut NA; Dave VS
AAPS PharmSciTech; 2015 Dec; 16(6):1344-56. PubMed ID: 25922089
[TBL] [Abstract][Full Text] [Related]
5. A comparison between povidone-ethylcellulose and povidone-eudragit transdermal dexamethasone matrix patches based on in vitro skin permeation.
Mukherjee B; Mahapatra S; Gupta R; Patra B; Tiwari A; Arora P
Eur J Pharm Biopharm; 2005 Apr; 59(3):475-83. PubMed ID: 15760728
[TBL] [Abstract][Full Text] [Related]
6. Transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics.
Ubaidulla U; Reddy MV; Ruckmani K; Ahmad FJ; Khar RK
AAPS PharmSciTech; 2007 Jan; 8(1):2. PubMed ID: 17408218
[TBL] [Abstract][Full Text] [Related]
7. Formulation design and in vitro ex vivo evaluation of transdermal patches of Cinnarizine.
Yamsani VV; Mudulaghar MK; Afreen S; Wajid S; Ravula SK; Babelghaith SD
Pak J Pharm Sci; 2017 Nov; 30(6):2075-2083. PubMed ID: 29175776
[TBL] [Abstract][Full Text] [Related]
8. PREPARATION, IN VITRO AND IN VIVO CHARACTERIZATION OF HYDROPHOBIC PATCHES OF A HIGHLY WATER SOLUBLE DRUG FOR PROLONGED PLASMA HALF LIFE: EFFECT OF PERMEATION ENHANCERS.
Yaqoob A; Ahmad M; Mahmood A; Sarfraz RM
Acta Pol Pharm; 2016 Nov; 73(6):1639-1648. PubMed ID: 29634120
[TBL] [Abstract][Full Text] [Related]
9. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt.
Arora P; Mukherjee B
J Pharm Sci; 2002 Sep; 91(9):2076-89. PubMed ID: 12210054
[TBL] [Abstract][Full Text] [Related]
10. Formulation development and investigation of domperidone transdermal patches.
Prabhu P; Shah S; Gundad S
Int J Pharm Investig; 2011 Oct; 1(4):240-6. PubMed ID: 23071950
[TBL] [Abstract][Full Text] [Related]
11. Design and Evaluation of Transdermal Patches of Timolol Maleate.
Panchayya Hiremath SS; Reddy JJ; Jamakandi VG
Curr Drug Deliv; 2018; 15(5):658-663. PubMed ID: 28969565
[TBL] [Abstract][Full Text] [Related]
12. Glibenclamide transdermal patches: physicochemical, pharmacodynamic, and pharmacokinetic evaluations.
Mutalik S; Udupa N
J Pharm Sci; 2004 Jun; 93(6):1577-94. PubMed ID: 15124215
[TBL] [Abstract][Full Text] [Related]
13. Design and Evaluation of Losartan Transdermal Patch by Using Solid Microneedles as A Physical Permeation Enhancer.
Almazan EA; Castañeda PS; Torres RD; Escobar-Chavez JJ
Iran J Pharm Res; 2020; 19(1):138-152. PubMed ID: 32922476
[TBL] [Abstract][Full Text] [Related]
14. Formulation and Evaluation of Hydrophilic Polymer Based Methotrexate Patches: In Vitro and In Vivo Characterization.
Latif MS; Al-Harbi FF; Nawaz A; Rashid SA; Farid A; Mohaini MA; Alsalman AJ; Hawaj MAA; Alhashem YN
Polymers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406184
[TBL] [Abstract][Full Text] [Related]
15. Design and evaluation of transdermal drug delivery system for curcumin as an anti-inflammatory drug.
Patel NA; Patel NJ; Patel RP
Drug Dev Ind Pharm; 2009 Feb; 35(2):234-42. PubMed ID: 18785045
[TBL] [Abstract][Full Text] [Related]
16. Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride.
Kusum Devi V; Saisivam S; Maria GR; Deepti PU
Drug Dev Ind Pharm; 2003 May; 29(5):495-503. PubMed ID: 12779279
[TBL] [Abstract][Full Text] [Related]
17. Transdermal therapeutic system of isradipine: effect of hydrophilic and hydrophobic matrix on in vitro and ex vivo characteristics.
Tirunagari M; Jangala VR; Khagga M; Gannu R
Arch Pharm Res; 2010 Jul; 33(7):1025-33. PubMed ID: 20661712
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of a losartan potassium released from a transdermal therapeutic system for the treatment of hypertension.
Shams MS; Alam MI; Ali A; Sultana Y; Aqil M; Shakeel F
Pharmazie; 2010 Sep; 65(9):679-82. PubMed ID: 21038845
[TBL] [Abstract][Full Text] [Related]
19. Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride.
Akram MR; Ahmad M; Abrar A; Sarfraz RM; Mahmood A
Drug Des Devel Ther; 2018; 12():349-364. PubMed ID: 29503528
[TBL] [Abstract][Full Text] [Related]
20. Design and evaluation of matrix diffusion controlled transdermal patches of coumarin.
Prabu SL; Thiyagarajan S; Suriyaprakash TN
Curr Drug Deliv; 2013 Apr; 10(2):167-73. PubMed ID: 22998642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
